Eureka Forbes Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 7:15 pm

Quick Insight

Eureka Forbes Ltd's current market dynamics reveal a share price of ₹573, supported by a P/E ratio of 69.5, indicating a premium valuation. Despite a modest ROE of 3.72% and ROCE of 5.07%, the company maintains a healthy OPM of 13%. With promoters holding a significant stake of 62.56% and strong financial backing evidenced by reserves of ₹4,191 Cr and manageable borrowings of ₹26 Cr, Eureka Forbes appears well-positioned for growth. The company's market capitalization of 11,086 Cr reflects investor confidence, with an ICR of 49.77x signaling a robust ability to service debt. Overall, Eureka Forbes' sound financial structure and strategic positioning suggest a potential for sustained performance in the domestic appliances industry.

Competitors of Eureka Forbes Ltd

All Competitor Stocks of Eureka Forbes Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:07 am

Below is a detailed analysis of the quarterly data for Eureka Forbes Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 613.00 Cr.. The value appears strong and on an upward trend. It has increased from 598.00 Cr. (Dec 2024) to 613.00 Cr., marking an increase of 15.00 Cr..
• For Expenses, as of Mar 2025, the value is 535.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 539.00 Cr. (Dec 2024) to 535.00 Cr., marking a decrease of 4.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Dec 2024) to 78.00 Cr., marking an increase of 19.00 Cr..
• For OPM %, as of Mar 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Dec 2024) to 13.00%, marking an increase of 3.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 15.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Dec 2024) to 68.00 Cr., marking an increase of 21.00 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Dec 2024) to 25.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is 51.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Dec 2024) to 51.00 Cr., marking an increase of 16.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.62. The value appears strong and on an upward trend. It has increased from 1.80 (Dec 2024) to 2.62, marking an increase of 0.82.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:32 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:20 pm

Below is a detailed analysis of the balance sheet data for Eureka Forbes Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 193.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 193.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,010.00 Cr. (Mar 2024) to 4,191.00 Cr., marking an increase of 181.00 Cr..
• For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 39.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,899.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,878.00 Cr. (Mar 2024) to 1,899.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 6,310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,120.00 Cr. (Mar 2024) to 6,310.00 Cr., marking an increase of 190.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 5,468.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,457.00 Cr. (Mar 2024) to 5,468.00 Cr., marking an increase of 11.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2024) to 84.00 Cr., marking an increase of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 758.00 Cr.. The value appears strong and on an upward trend. It has increased from 582.00 Cr. (Mar 2024) to 758.00 Cr., marking an increase of 176.00 Cr..
• For Total Assets, as of Mar 2025, the value is 6,310.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,120.00 Cr. (Mar 2024) to 6,310.00 Cr., marking an increase of 190.00 Cr..

Notably, the Reserves (4,191.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Eureka Forbes Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 8.46, marking an increase of 3.52.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 4.93 (Mar 24) to 8.46, marking an increase of 3.53.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 7.74 (Mar 24) to 11.49, marking an increase of 3.75.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.86. It has increased from 218.47 (Mar 24) to 227.86, marking an increase of 9.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.86. It has increased from 218.47 (Mar 24) to 227.86, marking an increase of 9.39.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 125.95. It has increased from 113.15 (Mar 24) to 125.95, marking an increase of 12.80.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.48. This value is within the healthy range. It has increased from 10.72 (Mar 24) to 14.48, marking an increase of 3.76.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.48. This value is within the healthy range. It has increased from 7.93 (Mar 24) to 11.48, marking an increase of 3.55.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 6.64 (Mar 24) to 11.41, marking an increase of 4.77.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 8.50, marking an increase of 3.56.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 8.50, marking an increase of 3.56.
• For PBDIT Margin (%), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 9.47 (Mar 24) to 11.49, marking an increase of 2.02.
• For PBIT Margin (%), as of Mar 25, the value is 9.11. This value is below the healthy minimum of 10. It has increased from 7.00 (Mar 24) to 9.11, marking an increase of 2.11.
• For PBT Margin (%), as of Mar 25, the value is 9.05. This value is below the healthy minimum of 10. It has increased from 5.86 (Mar 24) to 9.05, marking an increase of 3.19.
• For Net Profit Margin (%), as of Mar 25, the value is 6.74. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 6.74, marking an increase of 2.38.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.74. This value is below the healthy minimum of 8. It has increased from 4.36 (Mar 24) to 6.74, marking an increase of 2.38.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 15. It has increased from 2.26 (Mar 24) to 3.72, marking an increase of 1.46.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.12. This value is below the healthy minimum of 10. It has increased from 2.96 (Mar 24) to 4.12, marking an increase of 1.16.
• For Return On Assets (%), as of Mar 25, the value is 2.59. This value is below the healthy minimum of 5. It has increased from 1.56 (Mar 24) to 2.59, marking an increase of 1.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.39. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1.5. It has increased from 0.63 (Mar 24) to 0.83, marking an increase of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.57, marking an increase of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 4. It has increased from 3.47 (Mar 24) to 3.62, marking an increase of 0.15.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 49.77. This value is within the healthy range. It has increased from 21.22 (Mar 24) to 49.77, marking an increase of 28.55.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 29.47. This value is within the healthy range. It has increased from 12.34 (Mar 24) to 29.47, marking an increase of 17.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 10,267.49. It has increased from 8,769.60 (Mar 24) to 10,267.49, marking an increase of 1,497.89.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.21. This value exceeds the healthy maximum of 3. It has increased from 4.01 (Mar 24) to 4.21, marking an increase of 0.20.
• For EV / EBITDA (X), as of Mar 25, the value is 36.65. This value exceeds the healthy maximum of 15. It has decreased from 42.28 (Mar 24) to 36.65, marking a decrease of 5.63.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has increased from 4.04 (Mar 24) to 4.31, marking an increase of 0.27.
• For Price / BV (X), as of Mar 25, the value is 2.38. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.38, marking an increase of 0.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has increased from 4.04 (Mar 24) to 4.31, marking an increase of 0.27.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness